Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Hydroxyzine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 153Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Graviti's Generic Hydroxyzine Hydrochloride Receives Approval in the U.S.
    Graviti's Generic Hydroxyzine Hydrochloride Receives Approval in the U.S.

    17 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217652

    FDA
    17 Aug 2023
    Share Share
    Enforcement Report - Week of December 30, 2020
    Enforcement Report - Week of December 30, 2020

    30 Dec 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-30-2020-1609403374.pdf

    FDA
    30 Dec 2020
    Share Share
    Erfa Canada recalls ATARAX (hydroxyzine) due to resulting in a potential risk
    Erfa Canada recalls ATARAX (hydroxyzine) due to resulting in a potential risk

    09 Jun 2016

    // HEALTH CANADA

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58758a-eng.php

    HEALTH CANADA
    09 Jun 2016
    Share Share
    Dr Reddy's Lab completes acquisition of UCB's select brands
    Dr Reddy's Lab completes acquisition of UCB's select brands

    19 Jun 2015

    // PTI BUSINESS TODAY

    http://businesstoday.intoday.in/story/dr-reddy-lab-completes-acquisition-of-ucb-select-brands/1/220770.html

    PTI BUSINESS TODAY
    19 Jun 2015
    Share Share
    Akorn, Inc. initiates Class II recall of Hydroxyzine Hydrochloride due to Failed Impurities/Degradation Specifications
    Akorn, Inc. initiates Class II recall of Hydroxyzine Hydrochloride due to Failed Impurities/Degradation Specifications

    06 Jun 2015

    // FDA

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1129-2015&w=06172015&lang=eng

    FDA
    06 Jun 2015
    Share Share
    Advanced Physician Solutions, Inc. initiates Class II recall of Hydroxyzine Hydrochloride due to Lack of Assurance of Sterility
    Advanced Physician Solutions, Inc. initiates Class II recall of Hydroxyzine Hydrochloride due to Lack of Assurance of Sterility

    16 May 2015

    // FDA

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1099-2015&w=06032015&lang=eng

    FDA
    16 May 2015
    Share Share